Diagnostics News and Research

RSS

Johns Hopkins team develops urine-based test for prostate cancer detection

Researchers at the Johns Hopkins Kimmel Cancer Center, Johns Hopkins All Children's Hospital and four other institutions have devised a novel method to test for prostate cancer using biomarkers present in urine, funded in part by the National Institutes of Health.

9 Sep 2025

Study uncovers three-way relationships between gut fungi, genetics and disease risk

A new genome-wide study uncovers evidence of the first three-way relationships between human genetic variation, variation in the fungal component of the human microbiome - known as the mycobiome - and risk of developing chronic disease.

9 Sep 2025

Bedfont® to showcase the innovative Smokerlyzer® and NObreath® respiratory devices at ERS 2025

Bedfont® Scientific Limited, an innovative med-tech company with over 48 years of knowledge and expertise in the manufacture of medical breath analysis devices, are seeking new strategic distribution partners at this year's European Respiratory Society (ERS) Congress.

From Bedfont® Scientific Ltd 9 Sep 2025

New strategy for difficult-to-treat mesothelioma: Immunotherapy and ctDNA insights

People with operable diffuse pleural mesothelioma may benefit from immunotherapy before and after surgery, based on results of a clinical trial exploring the sequence of treatment and the role of surgery for this difficult to treat cancer.

8 Sep 2025

New technology could make MRI scanners cost-effective and more accessible

Revolutionary new technology could make MRI scanners cost effective, more widely available to local communities and help save lives, thanks to a pioneering collaboration between the University of Sheffield and GE HealthCare.

8 Sep 2025

NYU Langone strengthens world-leading GI cancer program with renowned leaders

NYU Langone Health's Perlmutter Cancer Center announces the arrival of acclaimed cancer leaders Anirban Maitra, MD, and Manuel Hidalgo, MD, as co-directors of a new Gastrointestinal (GI) Cancer Center.

5 Sep 2025

Blood-based biomarkers reveal barriers to diversity in Alzheimer’s disease trials

Some of the populations with the highest risk for Alzheimer's disease remain greatly underrepresented in clinical trials-and a new study helps explain why.

5 Sep 2025

Targeting ADAR1 offers new hope against glioblastoma

The most common and aggressive type of adult brain cancer, glioblastoma multiforme (GBM) is notoriously resistant to treatment, with a median survival of just 14 months following diagnosis.

5 Sep 2025

Radiometer, Leica Biosystems and Cepheid to come together at IBMS Congress 2025 on Stand 109

Radiometer urgent and acute care testing specialists, will unite with Leica Biosystems and Cepheid to spotlight the breadth and scale of the Danaher Diagnostics portfolio.

5 Sep 2025

HER2 and CD24 emerge as promising radiotheranostic targets in endometrial cancer

Two molecular targets-human epidermal growth factor 2 (HER2) and cluster of differentiation 24 (CD24)-are highly promising candidates for new nuclear diagnostics and therapeutics for endometrial cancer, according to new research published in The Journal of Nuclear Medicine.

5 Sep 2025

Breast cancer cells hijack iron-handling macrophages to promote bone metastasis and anemia

Breast cancers frequently spread to the bone, establishing tumors that are largely impervious to treatment and are associated with poor patient prognoses.

4 Sep 2025

Logical Biological launches sister company, Logical Antigen, delivering customized antigen and protein purification for IVD market

Logical Biological, biospecimen and critical material experts, today announced the launch of a new sister company, Logical Antigen, focused on rapid and customized delivery of high-quality antigens and biologicals, for research and manufacturing of diagnostic products.

From Logical Biological 4 Sep 2025

Beckman Coulter Life Sciences and HSE•AG partner to revolutionize nucleic acid quantification and purification through liquid handling

Beckman Coulter Life Sciences, a Danaher company and global leader in laboratory automation and innovation, is redefining nucleic acid quantification through a strategic collaboration with Hombrechtikon Systems Engineering•AG (HSE•AG), a Swiss provider of customized automation and engineering solutions for the life sciences and diagnostics sectors.

From Beckman Coulter Life Sciences 4 Sep 2025

Single antibody causes a rare but dangerous reaction to widely-used blood thinner

Researchers at McMaster University have discovered that a rare but dangerous reaction to a widely used blood thinner is caused by a single antibody – overturning decades of medical misunderstanding and opening the door to more precise ways of diagnosing and treating this medical complication.

3 Sep 2025

Hepatitis B immunity reduces diabetes risk across age groups

New research to be presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15-19 September) and published in the journal Diagnostics shows that people with hepatitis B immunity induced by vaccination have a lower risk of developing diabetes of any kind.

2 Sep 2025

Urine test identifies three biomarkers for accurate prostate cancer detection

2 Sep 2025

New drug dismantles cancer cell powerhouse to halt tumor growth

Researchers at MUSC Hollings Cancer Center have discovered a potentially powerful weapon in the fight against head and neck cancers.

2 Sep 2025

Study finds links between human genetic variation, gut mycobiome, and chronic disease risk

Clinicians' ability to diagnose and treat chronic diseases is limited by scientific uncertainty around factors contributing to disease risk. A study published September 2nd in the open-access journal PLOS Biology by Drs. Emily Van Syoc, Emily Davenport, and Seth Bordenstein at The Pennsylvania State University, United States, uncovers evidence of the first ternary relationships between human genetic variation, variation in gut mycobiome, and risk of developing chronic disease.

2 Sep 2025

Platelets found to mop up DNA fragments and improve early cancer detection

Platelets are probably best known for their role in blood clotting, making scabs and related, if less salubrious, contributions to heart attacks and strokes.

2 Sep 2025

MicroRNA panels show promise for improving prostate cancer diagnosis

Prostate cancer is highly heterogeneous, ranging from slow-growing tumors to aggressive, life-threatening disease.

2 Sep 2025

Diagnostics News and Research

Johns Hopkins team develops urine-based test for prostate cancer detection

Study uncovers three-way relationships between gut fungi, genetics and disease risk

Bedfont® to showcase the innovative Smokerlyzer® and NObreath® respiratory devices at ERS 2025

New strategy for difficult-to-treat mesothelioma: Immunotherapy and ctDNA insights

New technology could make MRI scanners cost-effective and more accessible

NYU Langone strengthens world-leading GI cancer program with renowned leaders

Blood-based biomarkers reveal barriers to diversity in Alzheimer’s disease trials

Targeting ADAR1 offers new hope against glioblastoma

Radiometer, Leica Biosystems and Cepheid to come together at IBMS Congress 2025 on Stand 109

HER2 and CD24 emerge as promising radiotheranostic targets in endometrial cancer

Breast cancer cells hijack iron-handling macrophages to promote bone metastasis and anemia

Logical Biological launches sister company, Logical Antigen, delivering customized antigen and protein purification for IVD market

Beckman Coulter Life Sciences and HSE•AG partner to revolutionize nucleic acid quantification and purification through liquid handling

Single antibody causes a rare but dangerous reaction to widely-used blood thinner

Hepatitis B immunity reduces diabetes risk across age groups

Urine test identifies three biomarkers for accurate prostate cancer detection

New drug dismantles cancer cell powerhouse to halt tumor growth

Study finds links between human genetic variation, gut mycobiome, and chronic disease risk

Platelets found to mop up DNA fragments and improve early cancer detection

MicroRNA panels show promise for improving prostate cancer diagnosis

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News